Search Results - "Mornex, F."

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study by Chauffert, B., Mornex, F., Bonnetain, F., Rougier, P., Mariette, C., Bouché, O., Bosset, J.F., Aparicio, T., Mineur, L., Azzedine, A., Hammel, P., Butel, J., Stremsdoerfer, N., Maingon, P., Bedenne, L.

“…The role of chemoradiation with systemic chemotherapy compared with chemotherapy alone in locally advanced pancreatic cancer (LAPC) is uncertain. One hundred…”
Get full text

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP) by Peters, S., Dafni, U., Boyer, M., De Ruysscher, D., Faivre-Finn, C., Felip, E., Garrido, P., Girard, N., Guckenberger, M., Haanen, J., Le Pechoux, C., Mornex, F., Ozsahin, M., Paz-Ares, L., Planchard, D., Raben, D., Ramalingam, S., Reck, M., Smit, E., Stahel, R., Stenzinger, A., Swanton, C., Vallone, S., Garassino, M.C.

Get full text

Radiation therapy of hepatic haemangiomas: Review from a case report by Mesny, E, Mornex, F, Rode, A, Merle, P

“…Haemangioma is the most frequent benign hepatic tumour. Haemangioma is generally asymptomatic but it can sometimes cause disabling symptoms depending on its…”
Get full text

Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery? by Kaiss, H, Mornex, F

“…Stereotactic radiotherapy (or Stereotactic body radiotherapy [SBRT]) is a technique currently well established in the therapeutic arsenal for the management of…”
Get full text

Hepatic tumours and radiotherapy by Rio, E., Mornex, F., Maingon, P., Peiffert, D., Parent, L.

“…We present the update of the recommendations of the French society of oncological radiotherapy on hepatic tumours. Recent technological progress led to develop…”
Get full text

Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone by Robb, W. B., Messager, M., Dahan, L., Mornex, F., Maillard, E., D'Journo, X. B., Triboulet, J.-P., Bedenne, L., Seitz, J.-F., Mariette, C.

“…Background Patterns of disease recurrence in patients with oesophageal cancer following treatment with neoadjuvant chemoradiotherapy and surgery (nCRTS) or…”
Get full text

Immunotherapy and radiotherapy by Bockel, S, Antoni, D, Deutsch, É, Mornex, F

“…Radiotherapy, primarily known for its cytotoxic effect on the tumor cells, via the induction of DNA damages, has the ability to induce a systemic antitumoral…”
Get full text

Radiotherapy for patient with cardiac implantable electronic device, consensus from French radiation oncology society by Escande, A., Frey, P., Lacornerie, T., Mervoyer, E., Chargari, C., Laurans, M., Mornex, F., Marijon, É., Giraud, P.

“…Radiotherapy in patients with cardiac implantable electronic device such as pacemakers or defibrillators, is a clinical situation that is becoming increasingly…”
Get full text

Lung metastases radiation therapy by Lévy, A., Darréon, J., Mornex, F., Giraud, P., Thureau, S.

“…We present an update of the French society of oncological radiotherapy recommendation regarding indication, doses, and technique of radiotherapy for…”
Get full text

Advances in the study of transmissible respiratory tumours in small ruminants by Monot, M., Archer, F., Gomes, M., Mornex, J.-F., Leroux, C.

“…Sheep and goats are widely infected by oncogenic retroviruses, namely Jaagsiekte Sheep RetroVirus (JSRV) and Enzootic Nasal Tumour Virus (ENTV). Under field…”
Get full text

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review by Le Scodan, R., Mornex, F., Girard, N., Mercier, C., Valette, P.-J., Ychou, M., Bibeau, F., Roy, P., Scoazec, J.-Y., Partensky, C.

“…We explored the feasibility and the histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic…”
Get full text

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study by Borg, C., André, T., Mantion, G., Boudghène, F., Mornex, F., Maingon, P., Adenis, A., Azria, D., Piutti, M., Morsli, O., Bosset, J.F.

“…In T3 rectal cancer (RC), preoperative chemoradiotherapy [5-fluorouracil (5-FU–RT)] reduces local recurrences, but does not affect overall survival. New…”
Get full text

Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen by Allignet, B., Merle, P., Rode, A., Mabrut, J.Y., Mohkam, K., Mornex, F.

“…In early-stage hepatocellular carcinoma (HCC) patients merely fit for surgery, transarterial chemoembolization (TACE) achieve low long-term disease control. We…”
Get full text

Radiotherapy for primary lung cancer by Khalifa, J., Lerouge, D., Le Péchoux, C., Pourel, N., Darréon, J., Mornex, F., Giraud, P.

“…Herein are presented the recommendations from the Société française de radiothérapie oncologique regarding indications and modalities of lung cancer…”
Get full text

Radiation therapy of pancreatic cancers by Huguet, F., Rivin del Campo, E., Orthuon, A., Mornex, F., Bessières, I., Guimas, V., Vendrely, V.

“…We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of pancreatic tumors. Currently, the use of…”
Get full text

Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients by Daccord, C, Cottin, V, Prévot, G, Uzunhan, Y, Mornex, J F, Bonniaud, P, Borie, R, Briault, A, Collonge-Rame, M A, Crestani, B, Devouassoux, G, Freynet, O, Gondouin, A, Hauss, P A, Khouatra, C, Leroy, S, Marchand-Adam, S, Marquette, C, Montani, D, Naccache, J M, Nadeau, G, Poulalhon, N, Reynaud-Gaubert, M, Salaun, M, Wallaert, B, Cordier, J F, Faouzi, M, Lazor, R

“…Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression…”
Get full text

Stereotactic body radiotherapy for liver tumors: State of the art by Riou, O, Azria, D, Mornex, F

“…Thanks to the improvement in radiotherapy physics, biology, computing and imaging, patients presenting with liver tumors can be efficiently treated by…”
Get full text

The 30th anniversary of SFRO, the French society of oncological radiotherapy by Mazeron, J-J, Mornex, F, Cosset, J-M, Eschwège, F

“…The French society of oncological radiotherapy (Société française de radiothérapie oncologique, SFRO) was created in 1990. On the occasion of its thirtieth…”
Get full text

Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists by Lazarescu, I., Dubray, B., Joulakian, M.B., Blanchard, P., Chauvet, B., Mahé, M.-A., Mornex, F., Rocher, F., Thureau, S.

“…Cancer caregivers are at high risk of burn-out, with potential severe consequences on professionals’ health and on patients’ care. We have investigated the…”
Get full text

T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction by Tissot, A., Lacoste, P., Roux, A., Reynaud‐Gaubert, M., Mussot, S., Botturi, K., Blanchard, E., Ruiz, M., Sokolow, Y., Vancutsem, N., Etienne, I., Arnaud‐Crozat, E., Chaffanjon, P., de Lambert, A., Fleury, J.P., Guigard, S., Porcu, P., Hacini, R., Albaladejo, P., Allègre, C., Bataillard, A., Briot, E., Durand, M., Francony, G., Marino, M.R., Protar, D., Robin, S., Boignard, A., Bouvaist, H., Chanoine, S., Maurizi, J., Pavèse, P., Wion, N., Chérion, C., Tronc, F., Glérant, J.‐C., Gamondes, D., Chalabresse, L., Barnel, C., Dubois, C., Tiberghien, A., Mordant, P., Méléard, D., Adda, M., Badier, M., Coltey, B., D'Journo, X.B., Dizier, S., Dufeu, N., Dutau, H., Gomez, C., Orsini, B., Roch, A., Rolain, J.M., Secq, V., Thomas, P., Trousse, D., Baron, O., Perigaud, C., Roussel, J.C., Danner, I., Morisset, M., Pares, S., Viard, P., Dorfmuller, P., Feuillet, S., Thomas de Montpreville, V., Lamrani, L., Cerceau, P., Augustin, P., Desmard, M., Dauriat, G., Marceau, A., Métivier, A.‐C., Thabut, G., Massard, G., Roche, A., Bakouboula, B., Kessler, L., Schuller, A., Vargas, S., Devaquet, J., Felten, M.L., Fischler, M., Leguen, M., Liu, N., Trebbia, G., Stern, M., Bouillioud, F., Cahen, P., Colombat, M., Delahousse, M., D'Urso, B., Gravisse, J., Temagoult, L., Vasse, M., Veyrie, C., Berjaud, J., Benahoua, H., Murris, M.

“…Chronic lung allograft dysfunction (CLAD) is the major limitation of long‐term survival after lung transplantation. CLAD manifests as bronchiolitis obliterans…”
Get full text